Core Laboratories Gains as 4Q View Looks Insulated from Tariffs

Dow Jones10-24
 

By Katherine Hamilton

 

Core Laboratories shares climbed after the energy-services company gave strong fourth-quarter guidance and said new tariff measures likely won't apply to most of its revenue sources.

The stock jumped 28%, to $16.36, on Thursday. Shares are still down 7% this year.

The company said it expects fourth-quarter revenue to be $132 million to $136 million, which would be ahead of the $128.6 million analysts were projecting, according to FactSet. Earnings per share are guided to be 18 cents to 22 cents, while analysts were forecasting 19 cents.

Core Laboratories believes the tariffs under consideration won't apply to the vast majority of its service revenue and product sales, it said. Services account for more than 75% of the Houston company's total revenue and currently aren't subject to tariffs.

Product sales have made up less than a quarter of total revenue and are primarily manufactured in the U.S. Tariffs on exported goods wouldn't apply to about half of those product sales, as they are consumed in the U.S. drilling and completion markets.

While tariff headwinds are contributing to market volatility and lower commodity prices right now, longer-term crude oil demand remains intact despite tariffs, the company said.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

October 23, 2025 12:18 ET (16:18 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment